» Articles » PMID: 3542658

Morphologic and Functional Changes in Sympathetic Nerve Relationships with Pancreatic Alpha-cells After Destruction of Beta-cells in Rats

Overview
Journal Diabetes
Specialty Endocrinology
Date 1987 Mar 1
PMID 3542658
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-dependent diabetes mellitus (IDDM) in humans is accompanied by an attenuation of the response of glucagon to hypoglycemia. To identify an animal model of IDDM with alpha-cell unresponsiveness to glucopenia in which to pursue morphologic and in vitro functional investigation of the lesion, pancreases isolated from rats with IDDM induced by streptozocin (STZ) or occurring spontaneously in BB/W rats were perfused with buffer containing 150, 25, and 150 mg/dl of glucose. In both forms of IDDM the normal glucagon rise during glucopenia was markedly impaired, suggesting an abnormality comparable to that of human IDDM. Studies of the insular sympathetic apparatus were conducted in these rat models. Electron-microscopic examination of peri-insular nerve endings disclosed no discernible abnormality in either form of rat IDDM. However, morphometric analysis of contacts between [3H]norepinephrine-labeled sympathetic nerve terminals and alpha-cells in pancreases from STZ-induced diabetic (STZ-D) rats revealed a 65-70% reduction in direct contacts. An 80% reduction in the number of nerve endings (not labeled) in direct contact with alpha-cells was also noted in the BB/W diabetic rats. Norepinephrine reuptake, studied only in the STZ-D group, was not impaired. The availability of local endogenous norepinephrine to alpha-cells and their sensitivity to exogenous norepinephrine was determined by perfusing 2, 5, or 10 micrograms/ml of tyramine, a releaser of endogenous norepinephrine, and norepinephrine at a concentration that in pancreases from nondiabetic rats gave a quantitatively similar glucagon response.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Human pancreatic capillaries and nerve fibers persist in type 1 diabetes despite beta cell loss.

Richardson T, Saunders D, Haliyur R, Shrestha S, Cartailler J, Reinert R Am J Physiol Endocrinol Metab. 2023; 324(3):E251-E267.

PMID: 36696598 PMC: 10027091. DOI: 10.1152/ajpendo.00246.2022.


Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes.

Campbell-Thompson M, Butterworth E, Boatwright J, Nair M, Nasif L, Nasif K Sci Rep. 2021; 11(1):6562.

PMID: 33753784 PMC: 7985489. DOI: 10.1038/s41598-021-85659-8.


The physiology of glucagon.

Taborsky Jr G J Diabetes Sci Technol. 2010; 4(6):1338-44.

PMID: 21129328 PMC: 3005043. DOI: 10.1177/193229681000400607.


Paracrinology of islets and the paracrinopathy of diabetes.

Unger R, Orci L Proc Natl Acad Sci U S A. 2010; 107(37):16009-12.

PMID: 20798346 PMC: 2941311. DOI: 10.1073/pnas.1006639107.


Neuronal elements in the pathogenesis of type 1 diabetes.

Tsui H, Winer S, Jakowsky G, Dosch H Rev Endocr Metab Disord. 2003; 4(3):301-10.

PMID: 14501181 DOI: 10.1023/a:1025374531151.